Laura A. Tookman

Charterhouse Square
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.

Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.

Journal: JAMA oncology
Published: June 25, 2026

Systematic curation and analysis of ovarian cancer data across multiple electronic record systems held within the UK National Health Service: a tertiary referral centre experience.

Systematic curation and analysis of ovarian cancer data across multiple electronic record systems held within the UK National Health Service: a tertiary referral centre experience.

Journal: ESMO real world data and digital oncology
Published: February 06, 2026

A Real-World Retrospective Observational Study of Patients with Advanced/Recurrent Endometrial Cancer Across England.

A Real-World Retrospective Observational Study of Patients with Advanced/Recurrent Endometrial Cancer Across England.

Journal: Oncology and therapy
Published: May 09, 2025

Homologous recombination deficiency testing in patients with high grade ovarian cancer: factors influencing test success.

Homologous recombination deficiency testing in patients with high grade ovarian cancer: factors influencing test success.

Journal: Future oncology (London, England)
Published: November 29, 2024

Mismatch in testing: a retrospective analysis of mismatch repair testing in endometrial cancer and Lynch syndrome diagnosis in multiple specialist centres in the UK and Ireland (March 2022-March 2023).

Mismatch in testing: a retrospective analysis of mismatch repair testing in endometrial cancer and Lynch syndrome diagnosis in multiple specialist centres in the UK and Ireland (March 2022-March 2023).

Journal: BMJ oncology
Published: November 28, 2024

What is the evidence for dietary modification in the management and prevention of malignant bowel obstruction? A scoping review.

What is the evidence for dietary modification in the management and prevention of malignant bowel obstruction? A scoping review.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 22, 2024

Diagnosis, treatment and burden in advanced ovarian cancer: a UK real-world survey of healthcare professionals and patients.

Diagnosis, treatment and burden in advanced ovarian cancer: a UK real-world survey of healthcare professionals and patients.

Journal: Future oncology (London, England)
Published: September 04, 2024

Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab.

Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: July 24, 2024

ESR Bridges: imaging and treatment of ovarian cancer-a multidisciplinary view.

ESR Bridges: imaging and treatment of ovarian cancer-a multidisciplinary view.

Journal: European radiology
Published: July 05, 2024

Understanding and Addressing Challenges With Electronic Health Record Use in Gynecological Oncology: Cross-Sectional Survey of Multidisciplinary Professionals in the United Kingdom and Co-Design of an Integrated Informatics Platform to Support Clinical Decision-Making.

Understanding and Addressing Challenges With Electronic Health Record Use in Gynecological Oncology: Cross-Sectional Survey of Multidisciplinary Professionals in the United Kingdom and Co-Design of an Integrated Informatics Platform to Support Clinical Decision-Making.

Journal: JMIR cancer
Published: March 21, 2024

The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions.

The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions.

Journal: The Journal of pathology
Published: February 23, 2024

The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden.

The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden.

Journal: Chemotherapy
Published: January 21, 2024
Showing 1-12 of 28

Last Updated: 09/26/2026